Corresponding Author

Lorenzo Leggio

Clinical Psychoneuroendocrinology and Neuropsychopharmacology Section, Translational Addiction Medicine Branch, National Institute on Drug Abuse and National Institute on Alcohol Abuse and Alcoholism, National Institutes of Health, Baltimore, Maryland, USA

Center on Compulsive Behaviors, National Institutes of Health, Bethesda, Maryland, USA

Medication Development Program, National Institute on Drug Abuse Intramural Research Program, National Institutes of Health, Baltimore, Maryland, USA

Center for Alcohol and Addiction Studies, Department of Behavioral and Social Sciences, School of Public Health, Brown University, Providence, Rhode Island, USA

Division of Addiction Medicine, Department of Medicine, School of Medicine, Johns Hopkins University, Baltimore, Maryland, USA

Department of Neuroscience, Georgetown University Medical Center, Washington, District of Columbia, USA

Correspondence

Lorenzo Leggio and Leandro F. Vendruscolo, NIDA and NIAAA, National Institutes of Health, 251 Bayview Boulevard, Biomedical Research Center, Room 01A844, Baltimore, MD 21224, USA.

Email: lorenzo.leggio@nih.gov; leandro.vendruscolo@nih.gov

Search for more papers by this author